Skip to main content
The Peptide Clinic

Recovery and repair peptide research

Everything on this page describes laboratory research. Compounds named here are supplied for in-vitro and analytical work by verified researchers only. None is a registered medicine in South Africa, none is approved for human or veterinary use, and nothing on this page is guidance for use in a person.

Apply for verified access

Recovery and repair covers peptides studied for their role in tissue remodelling: how connective tissue, muscle, tendon and gut lining behave in controlled models after mechanical or chemical injury. The published work in this area is overwhelmingly animal-model and cell-culture research, and that distinction matters. A result in a rodent tendon model or a cultured fibroblast line is a finding about that model, not a finding about human physiology.

CompoundsBPC-157, TB-500
The Clinic box with its silver THE Clinic wordmarkResearch peptide cartridge

What the research measures

Fibroblast behaviour

Migration and proliferation of fibroblasts in culture, since these are the cells that lay down the structural protein a repairing tissue is rebuilt from.

Angiogenesis

Formation of new blood vessels in injured tissue models. Repair is limited by perfusion, so vessel growth is a standard endpoint in this literature.

Extracellular matrix

Collagen deposition and how the surrounding matrix is organised, measured by histology and by tensile testing in animal-model work.

Inflammatory markers

Cytokine and inflammatory-marker profiles in injury models, which is where much of the disagreement in the literature sits.

Compounds studied in this area

BPC-157

Body Protection Compound-157

A synthetic pentadecapeptide, fifteen amino acids long, whose sequence corresponds to a partial fragment of a protein identified in human gastric juice. It is notably stable in acidic conditions relative to many peptides of similar length.

Published work is predominantly rodent-model and examines tendon-to-bone healing, gastrointestinal mucosal integrity and angiogenic signalling. Its acid stability is the reason a large share of that literature uses oral administration in animal models, which is unusual for a peptide of this class. Human clinical evidence is limited.

TB-500

Synthetic thymosin beta-4 fragment

A synthetic version of a short active fragment of thymosin beta-4, a naturally occurring protein involved in the regulation of actin, the cytoskeletal protein that governs cell shape and movement.

Research interest centres on actin sequestration and cell migration, since the ability of a cell to move into a wound site depends on actin dynamics. It appears in cardiac, corneal and dermal repair models. As with BPC-157, the weight of evidence is preclinical.

Laboratory handling and storage

Lyophilised peptide is the stable form. It is normally held below freezing and protected from light.

Reconstituted material has a substantially shorter working life than the lyophilised form, and that window is the usual limiting factor in planning an experiment.

Repeated freeze and thaw cycles degrade peptide integrity, so single-use aliquots are the standard practice.

Handling, reconstitution and disposal are laboratory procedures and should follow the receiving facility's own written procedures and local regulations.

Further reading